Abstract Purpose: To reduce the high recurrence rate of nephrolithiasis, patients are routinely prescribed secondary chemoprevention therapy with alkali citrate (AlkasolveĀ®; Sam-On Ltd) for uric acid stones and hypocitraturia or hydrochlorthiazide (DisothiazideĀ®; Dexcel Ltd) for hypercalciuria. However, data on adherence to these regimens are limited. The aim of this study was to...

Society Membership Required

This content is for society members only.

This content is for society members only.

Please sign in

Journal of Endourology

Endourological Society members receive full online access to the Journal of Endourology, Endourology Case Reports, and the Journal of VideoUrology.